The company Kroger Health said Tuesday that it plans to sell a smartphone-enabled, at-home Covid-19 test kit online and at pharmacies in the US.
The test, developed by Gauss and Cellex, has not yet received emergency use authorization from the US Food and Drug Administration, and cannot be sold until then. The company said it will share a price once the test is authorized.
Kroger said the rapid Covid-19 test can be performed using a smartphone and without involving a lab, telemedicine visit or specialized electronics. The company plans to sell the antigen test online and over the counter in pharmacies.
Gauss produced 1.5 million of the tests last month, Kroger said, and it has the capability to produce up to 30 million tests per month.
To take the test, users will follow video instructions, provided in an app, to collect a nasal swab and complete the test on their own.
After 15 minutes, patients will be prompted to scan their rapid test to get their results. To fulfill legal reporting requirements, the app shares results with public health agencies, Kroger said.